CUPR

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change +0.22
Percentage change 3.29	%

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.05	Insider Own	65.66%	Shs Outstand	7.37M	Perf Week	17.95%
Market Cap	148.01M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	7.37M	Perf Month	40.24%
Enterprise Value	148.11M	PEG	-	EPS next Q	-	Inst Own	-	Short Float	0.10%	Perf Quarter	-
Income	-1.17M	P/S	3700.13	EPS this Y	-	Inst Trans	-	Short Ratio	0.04	Perf Half Y	-
Sales	0.04M	P/B	-	EPS next Y	-	ROA	-	Short Interest	0.01M	Perf YTD	66.27%
Book/sh	-0.15	P/C	1644.50	EPS next 5Y	-	ROE	-	52W High	7.39 -6.63%	Perf Year	-
Cash/sh	0.00	P/FCF	-	EPS past 3/5Y	-45.12% -	ROIC	-	52W Low	3.51 96.58%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-6.00% -	Gross Margin	-72.91%	Volatility	13.48% 13.21%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3702.63	EPS Y/Y TTM	-	Oper. Margin	-3424.90%	ATR (14)	0.63	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.06	Sales Y/Y TTM	-	Profit Margin	-3249.91%	RSI (14)	70.64	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.06	EPS Q/Q	-	SMA20	17.68%	Beta	-	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	32.07%	Rel Volume	2.39	Prev Close	6.68
Employees	14	LT Debt/Eq	-	Earnings	-	SMA200	34.30%	Avg Volume	181.09K	Price	6.90
IPO	Apr 10, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	432,197	Change	3.29%

Jun-30-25 08:00AM	Cuprina Provides Update on Research Studies with Three Leading Education Institutes (GlobeNewswire)
Jun-04-25 08:00AM	Cuprina Completes Lab Able to Supply MEDIFLY Chronic Wound Therapy Across MENA Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries (GlobeNewswire)
May-08-25 01:05PM	Cuprina Holdings Announces Closing of Underwriter's Over-Allotment Option in Connection with Initial Public Offering (GlobeNewswire) -7.17%
May-06-25 10:45AM	Cuprina Holdings obtains dealer license for IVF media production facility (TipRanks) +5.38%
May-05-25 12:27PM	Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering (GlobeNewswire) -9.87%
12:24PM	Loading…
12:24PM	Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering (GlobeNewswire)
12:29PM	Cuprina Holdings Announces Completion, Receipt of Certification and License, for IVF Media Production Facility Built in Collaboration with Ferti-Craft Pte Ltd. (GlobeNewswire)
Apr-12-25 01:30AM	U.S. IPO Weekly Recap: Flurry Of Small Issuers List, Despite Heightened Market Volatility (Seeking Alpha)
Apr-11-25 11:07AM	Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering (GlobeNewswire) +7.95%
Apr-10-25 08:35AM	Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering (GlobeNewswire)

Cuprina Holdings (Cayman) Ltd. engages in the manufacturing, sale, and supply of medical devices to manage and accelerate healing and closure of chronic wounds. Its products include nature-based bioactive, in the form of advanced wound dressings, derived from sustainable sources. The company was founded by Carl Marc Baptista on August 28, 2019 and is headquartered in Singapore.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Cuprina Holdings (Cayman) Ltd

Upgrade your FINVIZ experience